The Chronic Obstructive Pulmonary Disease Market segment analysis indicates that inhalation therapies hold the largest share, followed by biologics and combination drugs. This segmentation allows targeted strategies for product development, marketing, and distribution to meet specific patient requirements. Global outlook projections reveal steady growth across all regions, with North America...